Amanda Schilly
Women's Health · Saint Louis, MONPI 1467902742
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $6,122 of the $7,689 with a category attached, or 79.6%. It is spread thinly across 32 manufacturers, the largest accounting for just 16.8% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,333, 2.8 times the $837 reported in 2021. Among women's health clinicians in MO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 326 payments — averaging $23.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biogen$1K
- AbbVie$1K
- Mayne Pharma Commercial LLC$816
- Evofem Biosciences, Inc.$629
- Amgen$530
- Astellas Pharma US Inc$491
- plus $3K from 26 others
What the payments were for
- Consulting fees$1,28817%
- Food & beverage$6,12280%
- Education$2794%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biogen | 1 | $1,288 |
| AbbVie | 64 | $1,055 |
| Mayne Pharma Commercial LLC | 52 | $816 |
| Evofem Biosciences, Inc. | 34 | $629 |
| Amgen | 26 | $530 |
| Astellas Pharma US Inc | 16 | $491 |
| Sage Therapeutics, LLC | 15 | $340 |
| Radius Health, Inc. | 11 | $286 |
| Hologic Sales And Service, LLC | 15 | $282 |
| Novo Nordisk | 9 | $228 |
| Sumitomo Pharma America, Inc. | 11 | $216 |
| UCB, Inc. | 2 | $189 |
| Myovant Sciences Inc. | 3 | $150 |
| Exeltis, USA Inc. | 7 | $137 |
| Millicent US Inc | 7 | $137 |
| Pfizer | 7 | $127 |
| Avion Pharmaceuticals | 8 | $122 |
| Idorsia Pharmaceuticals US Inc | 7 | $110 |
| Organon | 4 | $85 |
| Therapeuticsmd, Inc. | 4 | $62 |
| Agile Therapeutics, Inc. | 4 | $57 |
| Bayer | 3 | $51 |
| Optumhealth Care Solutions, LLC | 3 | $51 |
| Exact Sciences | 2 | $49 |
| Johnson & Johnson | 1 | $40 |
| Lupin Inc. | 2 | $35 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $30 |
| Merck | 2 | $27 |
| Shield Therapeutics Inc | 1 | $21 |
| Supernus Pharmaceuticals, Inc. | 1 | $17 |
| Boston Scientific | 1 | $17 |
| Scynexis, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,689 in reported general payments places this provider in the 95th percentile of 208 women's health providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| PremarinEstrogens, Conjugated | 24 | $8,559 |
| Estradiol | 68 | $1,612 |
| ProgesteroneProgesterone, Micronized | 28 | $1,217 |
| ValacyclovirValacyclovir Hcl | 18 | $986 |
| Estradiol (Once Weekly)Estradiol | 14 | $611 |
| Ibandronate Sodium | 16 | $304 |
| Medroxyprogesterone Acetate | 18 | $117 |
| Fluconazole | 13 | $84 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerPremarin | $127 | $8,55924 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 208 women's health providers in Missouri.
Other women's health in Saint Louis
- Nealya Bell-SilvaSaint Louis$107K
- Susan HoffstetterSaint Louis$39K
- Janice EislebenSaint Louis$16K
- Susan Mitchell-DerenskiSaint Louis$14K
- Kris ScalfSaint Louis$7K
- Savannah HayesSaint Louis$6K
- Kelly BallSaint Louis$4K
- Anna BartonSaint Louis$3K
- Amanda MetzSaint Louis$3K
- Rachel BenderSaint Louis$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.